CV Sciences, Inc.

CVSI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Assets
Cash & Equivalents $2.8M — — $2.3M $2.2M $431
Accounts Receivable $1.5M $360.5K $870.6K $282.4K $1.4M $0
Inventory $2.8M $2.9M $14.1M $11.7M $2.5M $0
Total Current Assets $7.9M $4.8M $16.6M $16.8M $8.1M $431
Property, Plant & Equipment $2.1M $242.7K $439.6K $516.4K $214.1K $0
Goodwill $2.8M $2.8M $4.6M $1.9M $1.9M $0
Intangible Assets (Excl. Goodwill) $3.8M $3.9M $5.6M $2.5M $3.4M $0
Total Assets $22.7M $18.6M $27.3M $21.7M $14.2M $431
Liabilities
Accounts Payable $678.0K $523.6K $659.4K $546.4K $24.6K $0
Total Current Liabilities $3.3M $3.1M $2.5M $664.6K $422.6K $500
Long-Term Debt $850.0K $679.2K $0 — — —
Total Liabilities $6.3M $5.4M $4.0M $664.6K $5.9M $500
Stockholders' Equity
Retained Earnings $-35.0M $-30.1M $-16.0M $-3.8M $-2.4M $-144.2K
Total Stockholders' Equity $16.4M $13.2M $23.3M $21.1M $8.3M $-69
← Newer Page 2 of 2 Older →